Archives of Gynecology and Obstetrics

, Volume 268, Issue 3, pp 198–201 | Cite as

Complications of in vitro fertilization with intracytoplasmic sperm injection in human immunodeficiency virus serodiscordant couples

  • Joseph E. Peña
  • Melvin H. ThorntonII
  • Mark V. Sauer
Original Article



Our experience with complications related to in vitro fertilization (IVF), particularly ovarian hyperstimulation syndrome (OHSS) and higher-order multiple gestations, in human immunodeficiency virus (HIV) serodiscordant couples undergoing IVF with intracytoplasmic sperm injection (ICSI) is presented.


We retrospectively evaluated 132 consecutive IVF-ICSI cycles and the ensuing 43 pregnancies in 74 HIV-seropositive male discordant couples. The diagnosis of moderate and severe OHSS was based on clinical criteria. Higher-order multiple gestations were defined as viable triplets or greater by the end of the first trimester verified by ultrasonography.


The incidence of moderate and severe OHSS was 4.5% of initiated IVF cycles. Seven of the 43 (16.3%) pregnancies were higher-order multiple gestations (1 quadruplet and 6 triplet pregnancies), resulting in the delivery of 3 sets of triplets and 3 sets of twins, with an ongoing twin pregnancy. Four patients had undergone multifetal pregnancy reduction to twins. There were no seroconversions in the women and the infants.


HIV serodiscordant couples undergoing fertility treatment with IVF-ICSI should be made particularly aware of the risks of higher-order multiple gestations and OHSS.


Human immunodeficiency virus In vitro fertilization Complications Multiple gestations Ovarian hyperstimulation syndrome 


  1. 1.
    ASRM Ethics Committee (2002) Human immunodeficiency virus and infertility treatment. Fertil Steril 77:218–222Google Scholar
  2. 2.
    ASRM Practice Committee Report (1999) Guidelines on number of embryos transferred. American Society of Reproductive Medicine, Birmingham, ALGoogle Scholar
  3. 3.
    Berkowitz RL, Lynch L, Stone J, Alvarez M (1996) The current status of multifetal pregnancy reduction. Am J Obstet Gynecol 174:1265–1272PubMedGoogle Scholar
  4. 4.
    Centers for Disease Control and Prevention (2002) 2000 Assisted reproductive technology success rates: national summary and fertility clinic reports. Centers for Disease Control and Prevention, Atlanta, GAGoogle Scholar
  5. 5.
    Chen JL, Philips KA, Kanouse DE, Collins RL, Miu A (2001) Fertility desires and intentions of HIV-positive men and women. Fam Plann Perspect 33:144–152; 165PubMedGoogle Scholar
  6. 6.
    Devine PC, Malone FD, Athanassiou A, Harvey-Wilkes K, D'Alton ME (2001) Maternal and neonatal outcome of 100 consecutive triplet pregnancies. Am J Perinatol 18:225–235CrossRefPubMedGoogle Scholar
  7. 7.
    Evans MI, Berkowitz RL, Wapner RJ, Carpenter RJ, Goldberg JD, Ayoub MA, Horenstein J, Dommergues M, Brambati B, Nicolaides KH, Holzgreve W, Timor-Tritsch IE (2001) Improvement in outcomes of multifetal pregnancy reduction with increased experience. Am J Obstet Gynecol 184:97–103CrossRefPubMedGoogle Scholar
  8. 8.
    Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, Lutalo T, Li X, vanCott T, Quinn TC (2001) Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357:1149–1153CrossRefPubMedGoogle Scholar
  9. 9.
    Hansen M, Kurinczuk JJ, Bower C, Webb S (2002) The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med 346:725–730Google Scholar
  10. 10.
    Loutradis D, Drakakis P, Kallianidis K, Patsoula E, Bletsa R, Michalas S (2001) Birth of two infants who were seronegative for human immunodeficiency virus type 1 (HIV-1) after intracytoplasmic injection of sperm from HIV-1-seropositive men. Fertil Steril 75:210–212Google Scholar
  11. 11.
    Malone FD, Kaufman GE, Chelmow D, Athanassiou A, Nores JA, D'Alton ME (1998) Maternal morbidity associated with triplet pregnancy. Am J Perinatol 15:73–77PubMedGoogle Scholar
  12. 12.
    Malone FD, Chelmow D, Athanassiou A, D'Alton ME (1999) Impact of gestational age at delivery of the economics of triplet pregnancy. J Matern Fetal Med 8:256–261PubMedGoogle Scholar
  13. 13.
    Marina S, Marina F, Alcolea R, Nadal J, Exposito R, Huguet J (1998) Pregnancy following intracytoplasmic sperm injection from an HIV-1-seropositive man. Hum Reprod 13:3247–3249CrossRefPubMedGoogle Scholar
  14. 14.
    Navot D, Bergh PA, Laufer N (1992) Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 58:249–261PubMedGoogle Scholar
  15. 15.
    Politch JA, Anderson DJ (2002) Preventing HIV-1 infection in women. Infertil Reprod Med Clin North Am 13:249–262Google Scholar
  16. 16.
    Sauer MV, Chang PL (2002) Establishing a clinical program for human immunodeficiency virus 1-seropositive men to father seronegative children by means of in vitro fertilization with intracytoplasmic sperm injection. Am J Obstet Gynecol 186:627–633CrossRefPubMedGoogle Scholar
  17. 17.
    Schenker JG (1999) Clinical aspects of ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol 85:13–20CrossRefPubMedGoogle Scholar
  18. 18.
    Schieve LA, Meikle SF, Ferre C, Peterson HB, Jeng G, Wilcox LS (2002) Low and very low birth weight in infants conceived with use of assisted reproductive technology. N Engl J Med 346:731–737Google Scholar
  19. 19.
    Schreiner-Engel P, Walther VN, Mindes J, Lynch L, Berkowitz RL (1995) First-trimester multifetal pregnancy reduction: acute and persistent psychologic reactions. Am J Obstet Gynecol 172:541–547PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Joseph E. Peña
    • 1
  • Melvin H. ThorntonII
    • 1
  • Mark V. Sauer
    • 1
  1. 1.Department of Obstetrics and Gynecology, Division of Reproductive EndocrinologyColumbia-Presbyterian Medical Center, Columbia University College of Physicians and SurgeonsNew YorkUSA

Personalised recommendations